Literature DB >> 24527946

Effect of delivery device on systemic exposure to inhaled fluticasone propionate in children with asthma.

Erik Nilsson1, Bo L K Chawes, Klaus Bønnelykke, Signe Vindfeld, Alison C Moore, Hans Bisgaard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24527946      PMCID: PMC4137838          DOI: 10.1111/bcp.12340

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in patients with mild-to-moderate asthma.

Authors:  C Falcoz; J Horton; A E Mackie; S M Harding; P T Daley-Yates
Journal:  Clin Pharmacokinet       Date:  2000       Impact factor: 6.447

2.  Absorption kinetics after inhalation of fluticasone propionate via the Diskhaler, Diskus and metered-dose inhaler in healthy volunteers.

Authors:  C Brindley; C Falcoz; A E Mackie; A Bye
Journal:  Clin Pharmacokinet       Date:  2000       Impact factor: 6.447

3.  Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration.

Authors:  H Möllmann; M Wagner; B Meibohm; G Hochhaus; J Barth; R Stöckmann; M Krieg; H Weisser; C Falcoz; H Derendorf
Journal:  Eur J Clin Pharmacol       Date:  1998-02       Impact factor: 2.953

4.  Aerosol particle size does not predict pharmacokinetic determined lung dose in children.

Authors:  Klaus Bønnelykke; Bo L K Chawes; Signe Vindfeld; Alison C Moore; Hans Bisgaard
Journal:  J Clin Pharmacol       Date:  2013-03-30       Impact factor: 3.126

5.  Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler.

Authors:  L Thorsson; S Edsbäcker; A Källén; C G Löfdahl
Journal:  Br J Clin Pharmacol       Date:  2001-11       Impact factor: 4.335

6.  Global strategy for asthma management and prevention: GINA executive summary.

Authors:  E D Bateman; S S Hurd; P J Barnes; J Bousquet; J M Drazen; J M FitzGerald; P Gibson; K Ohta; P O'Byrne; S E Pedersen; E Pizzichini; S D Sullivan; S E Wenzel; H J Zar
Journal:  Eur Respir J       Date:  2008-01       Impact factor: 16.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.